Seite 1 von 3
Literaturverzeichnis
zum Titelthema „Prävention in der Hals-, Nasen- und Ohrenheilkunde. Was ist gesichert – was ist Mythos?“
Bayerisches Ärzteblatt 1-2/2014, Seite 8 ff.
von Dr. Adam Chaker, Dr. univ. Benedikt Hofauer, Dr. Naglaa Mansour, Andreas Knopf und Dr. Thomas Stark
1. Hurrelmann, K., Haisch, Lehrbuch Prävention und Gesundheitsförderung. 2010(3).
2. Galazka, A.M., S.E. Robertson, and G.P. Oblapenko, Resurgence of diphtheria. Eur J Epidemiol, 1995. 11(1): p. 95-105.
3. Peckham, C.S., et al., Congenital rubella deafness: a preventable disease. Lancet, 1979. 1(8110): p. 258-61.
4. Hashimoto, H., M. Fujioka, and H. Kinumaki, An office-based prospective study of deafness in mumps. Pediatr Infect Dis J, 2009. 28(3): p. 173-5.
5. Niedermeyer, H.P. and W. Arnold, Otosclerosis and measles virus - association or causation? ORL J Otorhinolaryngol Relat Spec, 2008. 70(1): p. 63-9; discussion 69- 70.
6. Chaturvedi, A.K., et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol, 2011. 29(32): p. 4294-301.
7. D'Souza, G., et al., Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 2007. 356(19): p. 1944-56.
8. Kreimer, A.R., et al., Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol, 2013. 31(21): p. 2708-15.
9. Hong, A.M., et al., Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine, 2010. 28(19): p. 3269-72.
10. Herrero, R., et al., Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One, 2013. 8(7): p. e68329.
11. Azarpazhooh, A., et al., Xylitol for preventing acute otitis media in children up to 12 years of age. Cochrane Database Syst Rev, 2011(11): p. CD007095.
12. Doll, R. and A.B. Hill, Smoking and carcinoma of the lung; preliminary report. Br Med J, 1950. 2(4682): p. 739-48.
13. Mills, C.A. and M.M. Porter, Tobacco smoking habits and cancer of the mouth and respiratory system. Cancer Res, 1950. 10(9): p. 539-42.
14. Schrek, R., L.A. Baker, and et al., Tobacco smoking as an etiologic factor in disease;
cancer. Cancer Res, 1950. 10(1): p. 49-58.
15. Pantel, M. and O. Guntinas-Lichius, [Laryngeal carcinoma: epidemiology, risk factors and survival]. HNO, 2012. 60(1): p. 32-40.
Seite 2 von 3
16. Hoffman, H.T., et al., The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg, 1998. 124(9): p. 951-62.
17. CancerResearchUK, C.R., Laryngeal Cancer in UK.
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/larynx/incidence. am 10.12.2013.
18. Association Faculties of Medicine Canada, Primer on Population Health.
http://phprimer.afmc.ca/Part1-
TheoryThinkingAboutHealth/Chapter4BasicConceptsInPreventionSurveillanceAndHe althPromotion/Thestagesofprevention, 2013.
19. Robert Koch Institut, Hörstörungen und Tinnitus. Gesundheitsbericht des Bundes, 2006. 29: p. 3-39.
20. Twardella, D., et al., [Hearing loss in adolescents due to leisure noise. The OHRKAN study]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2011.
54(8): p. 965-71.
21. Leonhardt, A., Hören und Sprechen – Versuch einer Systematisierung und
Bestandsaufnahme. In: Ausbildung des Hörens – Erlernen des Sprechens. (edit. A.
Leonhardt), Luchterhand, Neuwied, 1998: p. 11-25.
22. Stark, T. and S. Helbig, [Cochlear implantation: a changing indication]. HNO, 2011.
59(6): p. 605-14.
23. Stark, T., G. Borkowski, and A. Hildmann, [Ototoxicity of cisplatin in children].
Laryngorhinootologie, 1999. 78(2): p. 73-6.
24. Cuffel, C. and J.P. Guyot, [Aspirin ototoxicity: a rare situation today]. Rev Med Suisse, 2013. 9(400): p. 1785-8.
25. Bousquet, J., et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy, 2008. 63 Suppl 86: p. 8-160.
26. Muche-Borowski, C., et al., Allergy prevention. Dtsch Arztebl Int, 2009. 106(39): p.
625-31.
27. Shaaban, R., et al., Rhinitis and onset of asthma: a longitudinal population-based study. Lancet, 2008. 372(9643): p. 1049-57.
28. Jacobsen, L., et al., Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy, 2007.
62(8): p. 943-8.
29. Calderon, M.A., et al., Allergen injection immunotherapy for seasonal allergic rhinitis.
Cochrane Database Syst Rev, 2007(1): p. CD001936.
30. Radulovic, S., et al., Systematic reviews of sublingual immunotherapy (SLIT). Allergy, 2011. 66(6): p. 740-52.
Seite 3 von 3
31. Anderson, H.R., J.M. Bland, and C.S. Peckham, Risk factors for asthma up to 16 years of age. Evidence from a national cohort study. Chest, 1987. 91(6 Suppl): p.
127S-130S.
32. van Hattum, E.S., et al., Adenoidectomy and/or tonsillectomy in childhood is not associated with atopic disease later in life. Clin Exp Allergy, 2006. 36(1): p. 40-3.
33. Suvilehto, J., et al., Association of allergy, asthma and IgE sensitisation to adenoidectomy and infections in children. Rhinology, 2007. 45(4): p. 286-91.
34. Busino, R.S., et al., The impact of adenotonsillectomy on asthma in children.
Laryngoscope, 2010. 120 Suppl 4: p. S221.
